Glenmark Pharmaceuticals launches Latanoprost Ophthalmic Solution in the US EP News Bureau Feb 14, 2025 Latanoprost Ophthalmic Solution, 0.005 per cent introduced as a bioequivalent alternative to Xalatan
Gland Pharma secures US FDA approval for Latanoprost Ophthalmic Solution EP News Bureau Dec 3, 2024 Product targets treatment of high intraocular pressure in glaucoma and ocular hypertension patients
